AbbVie Inc (NYSE:ABBV) - Share price - Overview

Stock Report

AbbVie Inc ABBV

Last Price
$62.22

Day Change
0.13|0.21%

As of 27/02/2017
17:05:35 EST | USD
Minimum 15 Minutes Delay.

Last Close62.09
Day Range61.68 - 62.37
Mkt Cap99.17Bil
52-Wk Range54.24 - 68.12
Yield %3.78
ISINUS00287Y1091
Volume5,214,091
P/E17.14
P/S3.96
P/CF14.41

Share Price

Financials
201420152016
More ...
Income Statement
Revenue19,960.0022,859.0025,638.00
Operating Income3,411.007,537.009,384.00
Net Income1,774.005,144.005,953.00
Basic EPS1.113.153.65
Avg. Diluted Shares Outstanding1,6101,6371,631
Balance Sheet
Current Assets16,088.0016,314.0016,187.00
Non Current Assets11,459.0036,736.0049,912.00
Total Assets27,547.0053,050.0066,099.00
Current Liabilities11,400.0010,894.009,781.00
Total Liabilities25,805.0049,105.0061,463.00
Total Equity1,742.003,945.004,636.00
Cash Flow
Operating Cash Flow3,549.007,535.007,041.00
Capital Expenditure-612.00-532.00-479.00
Free Cash Flow2,937.007,003.006,562.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

AbbVie Inc is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a broad line of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

30,000
Key Stats
More ...
Price/Earning TTM17.01
Price/Book21.35
Price/Sales TTM4.02
Rev Growth (3 year avg)10.91
EPS Growth (3 year avg)-
Operating Margin % TTM36.60
Net Margin % TTM23.22
ROE TTM138.05
Debt/Equity7.86
Dividends
PreviousLatest
More ...
Declared Date28/10/1616/02/17
Ex-Div11/01/1711/04/17
Paid15/02/1715/05/17
Amnt0.640.64
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.